Table 2.
Anamnestic characteristics of Czech HCWs responding to the HMPXV survey, September 2022 (n = 341).
| Variable | Outcome | HMPXV Vaccine Rejection (n = 153) |
HMPXV Vaccine Hesitancy (n = 158) |
HMPXV Vaccine Acceptance (n = 30) |
Total (n = 341) |
p |
|---|---|---|---|---|---|---|
| Total † | 58 (37.9%) | 63 (39.9%) | 11 (36.7%) | 132 (38.7%) | 0.912 | |
|
† Chronic Illnesses |
Allergy | 20 (34.5%) | 13 (20.6%) | 4 (36.4%) | 37 (28%) | 0.179 |
| Asthma | 16 (27.6%) | 15 (23.8%) | 4 (36.4%) | 35 (26.5%) | 0.634 | |
| Blood disease | 3 (5.2%) | 2 (3.2%) | 0 (0%) | 5 (3.8%) | 0.788 | |
| Bowel disease | 3 (5.2%) | 3 (4.8%) | 0 (0%) | 6 (4.5%) | 1.000 | |
| Cancer | 0 (0%) | 4 (6.3%) | 0 (0%) | 4 (3.0%) | 0.183 | |
| Cardiovascular disease | 1 (1.7%) | 3 (4.8%) | 1 (9.1%) | 5 (3.8%) | 0.280 | |
| Chronic hypertension | 19 (32.8%) | 20 (31.7%) | 2 (18.2%) | 41 (31.1%) | 0.718 | |
| COPD * | 1 (1.7%) | 2 (3.2%) | 1 (9.1%) | 4 (3.0%) | 0.381 | |
| Diabetes mellitus I | 0 (0%) | 1 (1.6%) | 0 (0%) | 1 (0.8%) | 1.000 | |
| Diabetes mellitus II | 4 (6.9%) | 2 (3.2%) | 0 (0%) | 6 (4.5%) | 0.662 | |
| Liver disease | 1 (1.7%) | 1 (1.6%) | 2 (18.2%) | 4 (3.0%) | 0.035 | |
| Psychological distress | 3 (5.2%) | 6 (9.5%) | 4 (36.4%) | 13 (9.8%) | 0.016 | |
| Neurological disorder | 3 (5.2%) | 7 (11.1%) | 3 (27.3%) | 13 (9.8%) | 0.071 | |
| Ophthalmologic disease | 4 (6.9%) | 5 (7.9%) | 0 (0%) | 9 (6.8%) | 1.000 | |
| Renal disease | 0 (0%) | 1 (1.6%) | 1 (9.1%) | 2 (1.5%) | 0.160 | |
| Rheumatoid arthritis | 3 (5.2%) | 2 (3.2%) | 0 (0%) | 5 (3.8%) | 0.788 | |
| Thyroid disease | 18 (31.0%) | 18 (28.6%) | 4 (36.4%) | 40 (30.3%) | 0.846 | |
| Other | 6 (10.3%) | 9 (14.3%) | 2 (18.2%) | 17 (12.9%) | 0.624 | |
| ‡ Medications | Total ‡ | 70 (45.8%) | 75 (47.5%) | 16 (53.3%) | 161 (47.2%) | 0.760 |
| Anti-asthmatics | 8 (11.4%) | 16 (21.3%) | 5 (31.3%) | 29 (18.0%) | 0.099 | |
| Anticoagulants | 3 (4.3%) | 2 (2.7%) | 0 (0%) | 5 (3.1%) | 0.807 | |
| Antidepressants | 5 (7.1%) | 6 (8.0%) | 6 (37.5%) | 17 (10.6%) | 0.006 | |
| Antidiabetics | 4 (5.7%) | 3 (4.0%) | 0 (0%) | 7 (4.3%) | 0.864 | |
| Antiepileptics | 1 (1.4%) | 1 (1.3%) | 1 (6.3%) | 3 (1.9%) | 0.450 | |
| Antihistamines | 15 (21.4%) | 8 (10.7%) | 1 (6.3%) | 24 (14.9%) | 0.139 | |
| Antihypertensives | 27 (38.6%) | 26 (34.7%) | 3 (18.8%) | 56 (34.8%) | 0.324 | |
| Anti-reflux | 5 (7.1%) | 6 (8.0%) | 3 (18.8%) | 14 (8.7%) | 0.295 | |
| Immunosuppressants | 2 (2.9%) | 4 (5.3%) | 0 (0%) | 6 (3.7%) | 0.832 | |
| Cholesterol-lowering | 8 (11.4%) | 11 (14.7%) | 2 (12.5%) | 21 (13.0%) | 0.887 | |
| Common analgesics | 1 (1.4%) | 4 (5.3%) | 3 (18.8%) | 8 (5.0%) | 0.027 | |
| Contraceptives | 9 (12.9%) | 7 (9.3%) | 2 (12.5%) | 18 (11.2%) | 0.709 | |
| Corticosteroids | 2 (2.9%) | 2 (2.7%) | 1 (6.3%) | 5 (3.1%) | 0.628 | |
| NSAIDs | 3 (4.3%) | 4 (5.3%) | 1 (6.3%) | 8 (5.0%) | 0.881 | |
| Opioid analgesics | 1 (1.4%) | 0 (0%) | 0 (0%) | 1 (0.6%) | 0.534 | |
| Thyroid hormones | 17 (24.3%) | 24 (32.0%) | 3 (18.8%) | 44 (27.3%) | 0.467 | |
| Other | 8 (11.4%) | 11 (14.7%) | 4 (25.0%) | 23 (14.3%) | 0.324 | |
| COVID-19 Vaccine |
Yes Ϯ | 129 (84.3%) | 152 (96.2%) | 30 (100.0%) | 311 (91.2%) | <0.001 |
| No | 24 (15.7%) | 6 (3.8%) | 0 (0%) | 30 (8.8%) | ||
| Ϯ COVID-19 Vaccine Doses | One dose | 3 (2.3%) | 2 (1.3%) | 0 (0%) | 5 (1.6%) | 0.798 |
| Two doses | 21 (16.3%) | 21 (13.8%) | 1 (3.3%) | 43 (13.8%) | 0.167 | |
| Three doses | 103 (79.8%) | 121 (79.6%) | 25 (83.3%) | 249 (80.1%) | 0.894 | |
| Four doses | 2 (1.6%) | 8 (5.3%) | 4 (13.3%) | 14 (4.5%) | 0.020 | |
| Influenza Vaccine |
Yes ψ | 43 (28.1%) | 71 (44.9%) | 17 (56.7%) | 131 (38.4%) | <0.001 |
| No | 110 (71.9%) | 87 (55.1%) | 13 (43.3%) | 210 (61.6%) | ||
| ψ Last 12 Months | Yes | 11 (25.6%) | 40 (56.3%) | 10 (58.8%) | 61 (46.6%) | 0.003 |
| No | 32 (74.4%) | 31 (43.7%) | 7 (41.2%) | 70 (53.4%) |
The chi-squared (χ2) test and Fisher’s exact test were used with a significance level (p) of ≤0.05. * COPD = chronic obstructive pulmonary disease. † refers to chronic illnesses. ‡ refers to medications. Ϯ refers to COVID-19 vaccinees. ψ refers to seasonal influenza vaccinees.